Cardiac protection during acute myocardial infarction: Where do we stand in 2004?
- 16 July 2004
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 44 (2) , 276-286
- https://doi.org/10.1016/j.jacc.2004.03.068
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- The Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1985
- Reduction of Infarct Size with the Early Use of Timolol in Acute Myocardial InfarctionNew England Journal of Medicine, 1984
- A Randomized Trial of Intracoronary Streptokinase in the Treatment of Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Effect of Intravenous Streptokinase on Acute Myocardial InfarctionNew England Journal of Medicine, 1982
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980
- Reduction of enzyme levels by propranolol after acute myocardial infarction.Circulation, 1978
- The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.Circulation, 1977
- Factors Influencing Infarct Size Following Experimental Coronary Artery OcclusionsCirculation, 1971